Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic. To read the full story.
Recent Posts
- Join NJ ACTS Genetically informed Research, Education, And Treatment (GREAT) Core TODAY at 10:30 am
- A Common Antihistamine Shows Promise in Treating Liver Complications of a Rare Disease.
- NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) Workshop Series on 2/20
- Collaboration Between NJIT, Rutgers, Temple Adds Security to AI Education.
- Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity.
Categories
- Community (2,133)
- Covid (981)
- CTO Events (6)
- News (2,722)
- Pilots (21)